Physician profile
Bruce Andrew Koplan
NPI 1083663298
$21,376.46
in general payments reported to CMS, 2019-2025
13 companies · $4,050 in 2025
The $4,050 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.68 · 2020: $39.64 · 2021: $40.22 · 2022: $19.26 · 2023: $9,641 · 2024: $7,524 · 2025: $4,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $2,352 · Travel and Lodging: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,702.00 |
| Food and Beverage | $2,351.58 |
| Travel and Lodging | $1,161.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $13,477.89 | 2023-2025 | |
| Biosense Webster, INC. | $2,872.61 | 2023-2025 | Smartablatetm System Rf Generator, Carto 3, Nuvision Ice Catheter |
| Atricure, INC. | $2,000.00 | 2023 | |
| Medtronic, INC. | $1,826.09 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Affera Mapping System |
| Boston Scientific Corporation | $732.67 | 2019-2025 | Emblem Mri S-Icd, Clinical Trial Product, Watchman Access System |
| Biotronik INC. | $153.32 | 2025 | |
| Cardiva Medical, INC. | $132.24 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Abbott Laboratories | $102.36 | 2019-2025 | Gallant |
| Davol INC. | $28.94 | 2025 | Arista |
| Cordis US Corp. | $27.88 | 2025 | Mynx Control Venous |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.46 | 2025 | Lifevest |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Koplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.